Cancer Research and Treatment

Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma

Tahereh Setayesh, Ying Hu, Farzam Vaziri, Xin Chen, Jinping Lai, Dongguang Wei, Yu-Jui Yvonne Wan

Acta Pharmaceutica Sinica B.2024; 14(1): 292. CrossRef

BCG as an Innovative Option for HCC Treatment: Repurposing and Mechanistic Insights

Farzam Vaziri, Tahereh Setayesh, Ying Hu, Resmi Ravindran, Dongguang Wei, Yu‐Jui Yvonne Wan

Photo-triggered caffeic acid delivery via psyllium polysaccharide- gellan gum-based injectable bionanogel for epidermoid carcinoma treatment

Sirajunnisa Abdul Razack, Yeachan Lee, Sivakumar Bose, Hwarang Shin, Won-Kyo Jung, Hyun Wook Kang

International Journal of Biological Macromolecules.2024; 267: 131166. CrossRef

Prognostic Factors after Hepatectomy for Hepatocellular Carcinoma—The Importance of Pathological Immunophenotyping, the Steatohepatitic Subtype and the Impact of the Hepatic Pedicle Clamping

Lorrane Viana, Rui Caetano Oliveira, Ricardo Martins, Henrique Alexandrino, Maria Augusta Cipriano, José Guilherme Tralhão

Gastrointestinal Disorders.2024; 6(2): 402. CrossRef

miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism

Ying Hu, Tahereh Setayesh, Farzam Vaziri, Xuesong Wu, Samuel T. Hwang, Xin Chen, Yu-Jui Yvonne Wan

Pan-cancer evaluation of clinical value of mitotic network activity index (MNAI) and its predictive value for immunotherapy

Xuanyu Mao, Yimeng Cai, Sarah Long, Jesus Perez-Losada, Jian-Hua Mao, Hang Chang

Differential expression of “A Disintegrin and Metalloproteinase 10” in hepatocellular carcinoma and the noncancerous hepatic tissues: Contribution to HCV-promoted hepatocarcinogenesis

Indian Journal of Pathology and Microbiology.2023; 66(3): 517. CrossRef

Hepatocellular Carcinoma's Characteristics in an Endemic Country: A Closer Examination of Tumor Grade and Microvascular Invasion

Ignasia Andhini Retnowulan, Marini Stephanie, Nur Rahadiani, Ridho Ardhi Syaiful, Ening Krisnuhoni

Siriraj Medical Journal.2023; 75(11): 817. CrossRef

Dependence of the Ki67 Labelling Index of Selected Canine Tumours on Patient Age, Sex and Tumour Size

Theresa C. Firsching, Kristina Dietert, Alexander Bartel, Marcus G. Doherr, Achim D. Gruber

Journal of Comparative Pathology.2022; 193: 1. CrossRef

CXCR2 inhibition enables NASH-HCC immunotherapy

Jack Leslie, John B G Mackey, Thomas Jamieson, Erik Ramon-Gil, Thomas M Drake, Frédéric Fercoq, William Clark, Kathryn Gilroy, Ann Hedley, Colin Nixon, Saimir Luli, Maja Laszczewska, Roser Pinyol, Roger Esteban-Fabró, Catherine E Willoughby, Philipp K Hab

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs

Annkathrin Estaller, Martin Kessler, Axel Wehrend, Johannes Hirschberger, Stephan Neumann

Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma

Sangjoon Choi, Keun-Woo Lee, Hyun Hee Koh, Sujin Park, So-Young Yeo, Jae-Won Joh, Moon Seok Choi, Seok-Hyung Kim, Cheol-Keun Park, Sang Yun Ha

Journal of Cancer Research and Clinical Oncology.2021; 147(12): 3517. CrossRef

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant TP53 or Wild-Type CTNNB1 Gene

Jiunn-Chang Lin, Tsang-Pai Liu, Vivin Andriani, Muhammad Athoillah, Chih-Yang Wang, Pei-Ming Yang

Journal of Personalized Medicine.2021; 11(11): 1199. CrossRef

Inositol 1,4,5‑trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma

Marcone Dos Santos, Andressa França, Antônio Lima Filho, Rodrigo Florentino, Paulo Diniz, Fernanda Lemos, Carlos Gonçalves, Vitor Coelho, Cristiano Lima, Giselle Foureaux, Michael Nathanson, Paula Vidigal, M. Leite

Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis

Amit Kumar Ram, Balasubramaniyan Vairappan, BH Srinivas

World Journal of Gastroenterology.2020; 26(45): 7131. CrossRef

Evaluation of the role of Notch1 expression in hepatic carcinogenesis with clinico-pathological correlation

Heba Hany, Asem Shalaby, Wagdi Al Kashef, Wageha Kandil, Rehab-Allah Shahin, Hatem El-Alfy, Tarek Besheer, Raghda Farag, Mie Mohamed

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

Sandhya Pranatharthiharan, Mitesh D. Patel, Vinod C. Malshe, Vaishali Pujari, Ajit Gorakshakar, Manisha Madkaikar, Kanjaksha Ghosh, Padma V. Devarajan